CPR for ALSCG
Joelle Caputa; firstname.lastname@example.org
Alliance Life Sciences Participates as Event Sponsor at ISPOR 16th Annual European Congress, Presents Examination of Biotech Industry’s Performance on the Stock Market
SOMERSET, N.J. – November 4, 2013– Alliance Life Sciences Consulting Group (ALSCG), an innovative management and technology consultancy, today announced that it will participate as an event sponsor at the International Society for Pharmoeconomics and Outcomes Research (ISPOR) 16th Annual European Congress, Nov. 2-6, 2013, The Convention Centre, Dublin, Ireland. At the meeting, ALSCG will display a study entitled, “Are Biotechnology and Pharmaceutical Sectors Defensive Within the Stock Market?”
“The study concluded that both the AMEX Pharmaceutical and Biotechnology Indices fell at a lesser rate than the S&P 500 during bear markets,” says Bruce Wang, Ph.D., vice president, HEOR, ALSCG. “The Pharmaceutical Index may be the more defensive play as it lost at an average annual rate of more than two times less than the S&P 500. However, the Biotechnology Index gained almost four times more than the Pharmaceutical Index and also outperformed the S&P 500 by almost 10 percentage points during bull markets. The reason is that when people are sick they seek care with little thought of price.”
The ISPOR 16th Annual European Congress will focus on how new European policies and patients stimulate change in new healthcare technology adoption. With over 2,000 abstract submissions, the event is expected to bring in record-breaking attendance of health payers, decision makers, technology assessors, regulators and governing bodies from around the world.
Wang adds, “ALSCG helps its customers maximize revenue and optimize pricing in an outcomes-based world. We employ hundreds of professionals around the globe who help firms obtain the greatest value in their initiatives at a time when the healthcare sector is widely regarded as being less elastic than other sectors.”
Alliance Life Sciences Consulting Group helps customers maximize revenue and pricing in an outcomes-based world. We employ hundreds of professionals who solve problems in Contracting, Pricing, Reimbursement, and Commercial Operations. We enable this mission in a healthcare world where the focus is on the patient’s well-being, the ultimate bottom line for everyone. Alliance works with 8 of the top-10 pharmaceutical manufacturers, and other life sciences companies. Contact: 866-581-4850 www.alscg.com